Dr. Oriol Iborra is CEO and co-founder of NIMBLE Diagnostics, a DeepTech spin-off developing the first non-invasive, non-ionizing system for continuous monitoring of implanted medical devices, with first focus on coronary stents. A cardiovascular researcher trained between Barcelona, Stanford and Harvard Medical School, he has authored 30+ publications and delivered 150+ international congress presentations. He combines strong clinical-scientific rigor with advanced training in entrepreneurship and life sciences management. As CEO, he leads financing strategy, investor relations and the company’s strategy toward creating a new standard of care for patients with implanted stents.